MFM Clinical Education Series

Obstetric Hemorrhage
& Massive Transfusion

Shock Index as an Early Warning Tool and Goal-Directed Hemostatic Resuscitation in Severe Postpartum Hemorrhage

ACOG SMFM FIGO 2025 Evidence-Based Clinical Practice
01
The Obstetric Shock Index

An objective, early predictor of hemodynamic instability in postpartum hemorrhage

Physiologic Basis
Why Standard Vital Signs Fail
50%
Physiologic plasma volume expansion in healthy pregnancy
Masked
Significant blood loss can occur with normal systolic BP
Delayed
Recognition of severe PPH when relying on isolated vital signs
Clinical Implication
The Shock Index compensates by indexing reactive tachycardia against normal or falling systolic blood pressure, providing an early warning of impending cardiovascular collapse.
Definition
The Shock Index Formula
SI = HR ÷ SBP
Heart Rate (bpm)  ÷  Systolic Blood Pressure (mmHg)
Primary Utility
Early Detection
Identifies hemodynamic instability, severe PPH, transfusion need, and ICU admission risk before BP drops
Guideline Adoption
FIGO 2025
Officially integrated into FIGO protocols for objective measurement and early detection of PPH
Clinical Thresholds
Shock Index Action Zones
SI Value Clinical Status Recommended Action
< 0.9 Reassuring hemodynamic status Standard postpartum monitoring
0.9 – 1.6 Intermediate risk / evolving hypovolemia Close observation • Quantify blood loss • Type & screen
≥ 1.7 Severe hypovolemic shock Urgent intervention • Prepare MTP • ICU notification

Data derived from established PPH risk thresholds (Nathan 2015; BJOG 2024)

Predictive Performance
SI vs. Systolic BP: ICU Admission
Shock Index
0.75
95% CI: 0.63 – 0.87
AUROC for ICU Admission
VS
Isolated Systolic BP
0.64
95% CI: 0.44 – 0.83
AUROC for ICU Admission
Dynamic Monitoring
Peak SI and delta SI (change over time) are strongly associated with composite adverse outcomes and predict the need for early blood transfusion.
Clinical Application
Delivery Mode Matters
▶
Vaginal Delivery
Validated
SI is an excellent, validated surrogate marker for PPH and hemodynamic instability following vaginal deliveries.
⚠
Cesarean Delivery
Reduced Accuracy
Spinal anesthesia induces sympathectomy, altering baseline vascular tone and heart rate responses, confounding standard SI calculation.
Multi-Marker Strategy
Combining early postpartum SI + serum lactate + Clauss fibrinogen (within 2 hours of placental delivery) significantly improves predictive capability over any single marker alone.
Limitations
Clinical Blind Spots
Hypertensive Disorders
Falsely Reassuring
Preeclampsia / chronic hypertension elevates baseline SBP. Massive hemorrhage may occur while SI appears normal or low.
Sensitivity Constraints
Never Alone
SI must be contextualized alongside quantitative blood loss, symptomatic hypovolemia, and the patient's baseline physiological status.
Clinical Principle
The Shock Index must never replace global clinical judgment. It is a tool to augment, not substitute, comprehensive hemodynamic assessment.
02
Massive Transfusion Protocol

Goal-directed hemostatic resuscitation in obstetric hemorrhage

Core Objective
The MTP Paradigm Shift
Old Paradigm
Crystalloid First
Large-volume crystalloid infusions predictably exacerbate dilutional coagulopathy and worsen outcomes.
Current Standard
Hemostatic Resuscitation
Early, rapid, fixed-ratio utilization of RBCs, plasma, and platelets as the primary resuscitative strategy.
90–95%
US academic obstetric centers with MTP
0.09–0.26%
MTP activation rate per delivery
Etiology of MTP Activation
Who Triggers the Protocol?
Obstetric Etiology % of Activations Pathophysiologic Mechanism Frequency
Uterine Atony 34 – 40% Failure of myometrial spiral artery compression
Abnormal Placentation 27 – 32% Neovascularization and failure of separation
Abruption / Previa 16% Consumptive coagulopathy and surgical bleeding
Retained Placenta 11% Focal myometrial atony and persistent vascular flow
Uterine Rupture 5% Catastrophic structural disruption and internal bleeding

Data from quality performance and transfusion incidence tracking cohorts

MTP Activation by Delivery Mode
When Does MTP Activate?
61%
Cesarean Delivery
32%
Vaginal Delivery
7%
Dilation & Evacuation
National Context
Obstetric hemorrhage accounts for 11.4% of all maternal deaths in the United States. Rapid recognition and MTP deployment across all bleeding etiologies is critical.
Hemostatic Resuscitation
Optimal Blood Product Ratios
FFP : RBC   ≥ 1 : 1
Fresh Frozen Plasma to Red Blood Cell Ratio Target
RBCs
Oxygen Delivery
Restore circulating volume and tissue oxygen delivery
Fresh Frozen Plasma
Coagulation Factors
Replace all clotting factors; ratio ≥1 improves survival
Platelets
Primary Plug
Facilitate platelet-fibrinogen interactions for clot formation
Coagulopathy Management
Fibrinogen: The Critical Target
First to Deplete
Earliest Casualty
Fibrinogen is consistently the first clotting factor to reach critically low levels during massive obstetric bleeding.
Dual Role
Indispensable
Primary substrate for thrombin-mediated fibrin generation AND facilitates primary plug via GP IIb/IIIa platelet receptors.
Mandatory Action
Continuous monitoring and rapid reversal of fibrinogen depletion are urgent therapeutic endpoints. In abruption and IUFD, severe hypofibrinogenemia precedes standard markers of hypovolemia — empiric replacement is mandatory.
Clinical Execution
The ABCD Framework
A
Assessment / Activation
Immediate recognition of uncontrolled hemorrhage and rapid deployment of the hospital-specific MTP.
B
Blood Products
Balanced, fixed-ratio RBCs, FFP, and platelets. Target FFP:RBC ratio ≥1.
C
Complications
Aggressive correction of dilutional coagulopathy, acidemia, and hypothermia — the lethal triad.
D
Drugs
Pharmacologic adjuncts including tranexamic acid, fibrinogen concentrate, cryoprecipitate, and rFVIIa when indicated.
Quality Performance
Operational Vulnerabilities
Overactivation Rate
~12%
MTP activated but <2 RBC units transfused. Over-transfusion outpaces under-transfusion.
Debriefing Compliance
Frequently Omitted
Post-event debriefing — critical for identifying system gaps — is often undocumented after MTP termination.
Team Exposure
Low Frequency
Genuine massive obstetric hemorrhage is statistically rare, limiting repetitive team exposure and protocol compliance.
Mitigation Strategy
Maintain rigid hospital-specific quality indicators and conduct regular multidisciplinary simulation drills to ensure flawless MTP execution during rare, high-stakes events.
Clinical Summary
Key Takeaways
Shock Index
Early Warning
SI ≥1.7 mandates urgent intervention. Validated for vaginal delivery; use multi-marker approach for cesarean. Never replace clinical judgment.
MTP Ratios
FFP:RBC ≥ 1
Fixed-ratio hemostatic resuscitation improves survival. Limit crystalloids. Prioritize early fibrinogen monitoring and replacement.
Fibrinogen
First to Deplete
Empiric replacement mandatory in abruption and IUFD. Hypofibrinogenemia precedes clinical hypovolemia in these scenarios.
Quality Assurance
Drill & Debrief
Regular multidisciplinary simulation and mandatory post-event debriefing are essential to maintain protocol fidelity.
← OpenMFM Library